GSK reveals data on novel gonorrhoea drug gepotidacin
18 Apr 2024 //
PRESS RELEASE
GSK Posts Positive Phase III Gonorrhea Results for Antibiotic Gepotidacin
27 Feb 2024 //
BIOSPACE
GSK halts successful UTI trials early, preps FDA submission
04 Nov 2022 //
FIERCEBIOTECH